Cargando…
Prognostic stromal gene signatures in breast cancer
INTRODUCTION: Global gene expression analysis of tumor samples has been a valuable tool to subgroup tumors and has the potential to be of prognostic and predictive value. However, tumors are heterogeneous, and homogenates will consist of several different cell types. This study was designed to obtai...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360948/ https://www.ncbi.nlm.nih.gov/pubmed/25848820 http://dx.doi.org/10.1186/s13058-015-0530-2 |
_version_ | 1782361601597243392 |
---|---|
author | Winslow, Sofia Leandersson, Karin Edsjö, Anders Larsson, Christer |
author_facet | Winslow, Sofia Leandersson, Karin Edsjö, Anders Larsson, Christer |
author_sort | Winslow, Sofia |
collection | PubMed |
description | INTRODUCTION: Global gene expression analysis of tumor samples has been a valuable tool to subgroup tumors and has the potential to be of prognostic and predictive value. However, tumors are heterogeneous, and homogenates will consist of several different cell types. This study was designed to obtain more refined expression data representing different compartments of the tumor. METHODS: Formalin-fixed paraffin-embedded stroma-rich triple-negative breast cancer tumors were laser-microdissected, and RNA was extracted and processed to enable microarray hybridization. Genes enriched in stroma were identified and used to generate signatures by identifying correlating genes in publicly available data sets. The prognostic implications of the signature were analyzed. RESULTS: Comparison of the expression pattern from stromal and cancer cell compartments from three tumors revealed a number of genes that were essentially specifically expressed in the respective compartments. The stroma-specific genes indicated contribution from fibroblasts, endothelial cells, and immune/inflammatory cells. The gene set was expanded by identifying correlating mRNAs using breast cancer mRNA expression data from The Cancer Genome Atlas. By iterative analyses, 16 gene signatures of highly correlating genes were characterized. Based on the gene composition, they seem to represent different cell types. In multivariate Cox proportional hazard models, two immune/inflammatory signatures had opposing hazard ratios for breast cancer recurrence also after adjusting for clinicopathological variables and molecular subgroup. The signature associated with poor prognosis consisted mainly of C1Q genes and the one associated with good prognosis contained HLA genes. This association with prognosis was seen for other cancers as well as in other breast cancer data sets. CONCLUSIONS: Our data indicate that the molecular composition of the immune response in a tumor may be a powerful predictor of cancer prognosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-015-0530-2) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4360948 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43609482015-03-17 Prognostic stromal gene signatures in breast cancer Winslow, Sofia Leandersson, Karin Edsjö, Anders Larsson, Christer Breast Cancer Res Research Article INTRODUCTION: Global gene expression analysis of tumor samples has been a valuable tool to subgroup tumors and has the potential to be of prognostic and predictive value. However, tumors are heterogeneous, and homogenates will consist of several different cell types. This study was designed to obtain more refined expression data representing different compartments of the tumor. METHODS: Formalin-fixed paraffin-embedded stroma-rich triple-negative breast cancer tumors were laser-microdissected, and RNA was extracted and processed to enable microarray hybridization. Genes enriched in stroma were identified and used to generate signatures by identifying correlating genes in publicly available data sets. The prognostic implications of the signature were analyzed. RESULTS: Comparison of the expression pattern from stromal and cancer cell compartments from three tumors revealed a number of genes that were essentially specifically expressed in the respective compartments. The stroma-specific genes indicated contribution from fibroblasts, endothelial cells, and immune/inflammatory cells. The gene set was expanded by identifying correlating mRNAs using breast cancer mRNA expression data from The Cancer Genome Atlas. By iterative analyses, 16 gene signatures of highly correlating genes were characterized. Based on the gene composition, they seem to represent different cell types. In multivariate Cox proportional hazard models, two immune/inflammatory signatures had opposing hazard ratios for breast cancer recurrence also after adjusting for clinicopathological variables and molecular subgroup. The signature associated with poor prognosis consisted mainly of C1Q genes and the one associated with good prognosis contained HLA genes. This association with prognosis was seen for other cancers as well as in other breast cancer data sets. CONCLUSIONS: Our data indicate that the molecular composition of the immune response in a tumor may be a powerful predictor of cancer prognosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-015-0530-2) contains supplementary material, which is available to authorized users. BioMed Central 2015-02-21 2015 /pmc/articles/PMC4360948/ /pubmed/25848820 http://dx.doi.org/10.1186/s13058-015-0530-2 Text en © Winslow et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Winslow, Sofia Leandersson, Karin Edsjö, Anders Larsson, Christer Prognostic stromal gene signatures in breast cancer |
title | Prognostic stromal gene signatures in breast cancer |
title_full | Prognostic stromal gene signatures in breast cancer |
title_fullStr | Prognostic stromal gene signatures in breast cancer |
title_full_unstemmed | Prognostic stromal gene signatures in breast cancer |
title_short | Prognostic stromal gene signatures in breast cancer |
title_sort | prognostic stromal gene signatures in breast cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360948/ https://www.ncbi.nlm.nih.gov/pubmed/25848820 http://dx.doi.org/10.1186/s13058-015-0530-2 |
work_keys_str_mv | AT winslowsofia prognosticstromalgenesignaturesinbreastcancer AT leanderssonkarin prognosticstromalgenesignaturesinbreastcancer AT edsjoanders prognosticstromalgenesignaturesinbreastcancer AT larssonchrister prognosticstromalgenesignaturesinbreastcancer |